UBS Group’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.76M | Buy |
|
|||||
|
2025
Q1 | $2.07M | Buy |
|
|||||
|
2024
Q4 | $1.92M | Buy |
|
|||||
|
2024
Q3 | $1.1M | Buy |
|
|||||
|
2024
Q2 | $783K | Sell |
|
|||||
|
2024
Q1 | $1.01M | Sell |
|
|||||
|
2023
Q4 | $2.28M | Buy |
|
|||||
|
2023
Q3 | $1.49M | Sell |
|
|||||
|
2023
Q2 | $2.35M | Buy |
|
|||||
|
2023
Q1 | $1.44M | Buy |
|
|||||
|
2022
Q4 | $201K | Buy |
|
|||||
|
2022
Q3 | $276K | Sell |
|
|||||
|
2022
Q2 | $1.51M | Sell |
|
|||||
|
2022
Q1 | $2.17M | Buy |
|
|||||
|
2021
Q4 | $2.6M | Sell |
|
|||||
|
2021
Q3 | $5.26M | Sell |
|
|||||
|
2021
Q2 | $3.37M | Buy |
|
|||||
|
2021
Q1 | $3.31M | Buy |
|
|||||
|
2020
Q4 | $2.99M | Buy |
|
|||||
|
2020
Q3 | $2.49M | Buy |
|
|||||
|
2020
Q2 | $1.65M | Sell |
|
|||||
|
2020
Q1 | $1.78M | Buy |
|
|||||
|
2019
Q4 | $1.68M | Buy |
|
|||||
|
2019
Q3 | $38K | Buy |
|
|||||
|
2019
Q2 | $42K | Sell |
|
|||||
|
2019
Q1 | $46K | Sell |
|
|||||
|
2018
Q4 | $55K | Sell |
|
|||||
|
2018
Q3 | $857K | Buy |
|
|||||
|
2018
Q2 | $678K | Buy |
|
|||||
|
2018
Q1 | $599K | Sell |
|
|||||
|
2017
Q4 | $538K | Buy |
|
|||||
|
2017
Q3 | $582K | Sell |
|
|||||
|
2017
Q2 | $604K | Sell |
|
|||||
|
2017
Q1 | $824K | Buy |
|
|||||
|
2016
Q4 | $208K | Buy |
|
|||||
|
2016
Q3 | $209K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $6K | Sell |
|
|||||
|
2015
Q4 | $42K | Buy |
|